advisorsecurities master

LONALeonaBio, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
18135
Ticker
LONA
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-09-18
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
LONA

Detail

Enriched 2026-08-14 20:47

Market cap
$73,926,955.18
Shares outstanding (class)
9,393,514
Shares outstanding (weighted)
9,393,514
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
19
Location
BOTHELL, WA
Description

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data